+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
KABRADG KABRADG

Kabra Drugs Share Price

₹17.85 +0.46 (2.65%)
New 52W Low in past week

09 Nov, 2026 4:01 PM (IST)

Kabra Drugs live price: ₹17.85. It opened at ₹18 vs previous close ₹17; intraday high/low: ₹18/₹18. The 50 & 200 DMA stand at ₹18.30/₹21.50.

Kabra Drugs Performance

  • Today's Low
  • ₹18
  • Today's High
  • ₹18
  • 52 Week Low
  • ₹15
  • 52 Week High
  • ₹36
  • Open Price₹18
  • Previous Close₹17
  • Volume42,611
  • 50 DMA₹18.30
  • 100 DMA₹20.10
  • 200 DMA₹21.50

Kabra Drugs Chart

Investment Returns

  • Over 1 Month -2.25%
  • Over 3 Month -26.63%
  • Over 6 Month -33.52%
  • Over 1 Year -8.18%

Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!

Invest Now

Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 5.5
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 42
  • P/B Ratio
  • 1.3
  • Average True Range
  • 1.4
  • EPS
  • 3.2
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.5
  • RSI
  • 55.09
  • MFI
  • 45.62

Latest Stock News Updates

Kabra Drugs Ltd - 524322 - Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On 30Th September 2026

Undertaking for Non-Applicability of Regulation 32 of SEBI (LODR)

Kabra Drugs Ltd - 524322 - Financial Results For The Quarter Ended 30-September-2026

Financial Results for the quarter ended 30-September-2026.

Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On 06-November-2026, As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Outcome of Board Meeting held on 06-November-2026

Kabra Drugs Financials

Kabra Drugs Technicals

EMA & SMA

Current Price
₹17.85
+ 0.46 (2.65%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹16.90
  • 50 Day
  • ₹18.30
  • 100 Day
  • ₹20.10
  • 200 Day
  • ₹21.50

Resistance and Support

17.95 Pivot Speed
  • R3 19.00
  • R2 18.70
  • R1 18.20
  • S1 17.50
  • S2 17.20
  • S3 16.70

Kabra Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-06 Quarterly Results
2026-09-02 Others
2026-08-12 Quarterly Results
2026-05-29 Quarterly Results
2026-05-06 Others Inter-alia, to consider 1. Pharmaceutical manufacturing & marketing expansion of own brands. 2. Defense & AI Integration: To evaluate opportunities in defense manufacturing. 3. Other business matters.

Kabra Drugs Shareholding Pattern

100.01%
0%
0%

Kabra Drugs FAQs

Kabra Drugs share price is ₹17 As on 10 November, 2026 | 20:35

The Market Cap of Kabra Drugs is ₹42.3 Cr As on 10 November, 2026 | 20:35

The P/E ratio of Kabra Drugs is 5.5 As on 10 November, 2026 | 20:35

The PB ratio of Kabra Drugs is 1.3 As on 10 November, 2026 | 20:35

The 52 week High & Low of Kabra Drugs is ₹35.5/₹15.2 respectively As on 10 November, 2026 | 20:35

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23